Evidence map›Paper›PMID 28147323›Full record

ArticleOncotarget2017

The DNA repair function of CUX1 contributes to radioresistance.

Zubaidah M Ramdzan, Vasudeva Ginjala, Jordan B Pinder, Dudley Chung, Caroline M Donovan, Simran Kaur, Lam Leduy, Graham Dellaire, Shridar Ganesan, Alain Nepveu

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Targets for protection and mitigation of radiation injury.Cellular and molecular life sciences : CMLS · 2020
    Review
  18. Inhibitors of DNA Glycosylases as Prospective Drugs.International journal of molecular sciences · 2020
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Zubaidah M RamdzanGoodman Cancer Research Centre, McGill University, Montreal, Quebec, H3A 1A3, Canada.
Vasudeva GinjalaDepartment of Medicine, Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, New Jersey 08903, USA.
Jordan B PinderDepartment of Pathology, Dalhousie University, Halifax, Nova Scotia, B3H 4R2, Canada.
Dudley ChungDepartment of Pathology, Dalhousie University, Halifax, Nova Scotia, B3H 4R2, Canada.
Caroline M DonovanGoodman Cancer Research Centre, McGill University, Montreal, Quebec, H3A 1A3, Canada.
Simran KaurGoodman Cancer Research Centre, McGill University, Montreal, Quebec, H3A 1A3, Canada.
Lam LeduyGoodman Cancer Research Centre, McGill University, Montreal, Quebec, H3A 1A3, Canada.
Graham DellaireDepartment of Pathology, Dalhousie University, Halifax, Nova Scotia, B3H 4R2, Canada.
Shridar GanesanDepartment of Medicine, Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, New Jersey 08903, USA.
Alain NepveuGoodman Cancer Research Centre, McGill University, Montreal, Quebec, H3A 1A3, Canada.
McGill University · CA

Funding

53BP1-Mediated Regulation of DNA Repair and ChemoresistanceR01CA169182 · NCI · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI GANESAN, SHRIDAR · 2012 to 2016
$1.6M
NCI NIH HHS R01 CA169182
6 · The paper itself

Abstract

Ionizing radiation generates a broad spectrum of oxidative DNA lesions, including oxidized base products, abasic sites, single-strand breaks and double-strand breaks. The CUX1 protein was recently shown to function as an auxiliary factor that stimulates enzymatic activities of OGG1 through its CUT domains. In the present study, we investigated the requirement for CUX1 and OGG1 in the resistance to radiation. Cancer cell survival following ionizing radiation is reduced by CUX1 knockdown and increased by higher CUX1 expression. However, CUX1 knockdown is sufficient by itself to reduce viability in many cancer cell lines that exhibit high levels of reactive oxygen species (ROS). Consequently, clonogenic results expressed relative to that of non-irradiated cells indicate that CUX1 knockdown confers no or modest radiosensitivity to cancer cells with high ROS. A recombinant protein containing only two CUT domains is sufficient for rapid recruitment to DNA damage, acceleration of DNA repair and increased survival following radiation. In agreement with these findings, OGG1 knockdown and treatment of cells with OGG1 inhibitors sensitize cancer cells to radiation. Together, these results validate CUX1 and more specifically the CUT domains as therapeutic targets.

Indexed as

Cell Line, TumorDNA GlycosylasesDNA RepairGene Knockdown TechniquesHomeodomain ProteinsHumansImmunoblottingMicroscopy, ConfocalNuclear ProteinsPolymerase Chain ReactionRadiation ToleranceReactive Oxygen SpeciesRepressor ProteinsTranscription FactorsCUX1 protein, humanDNA GlycosylasesHomeodomain ProteinsNuclear Proteinsoxoguanine glycosylase 1, humanReactive Oxygen SpeciesRepressor ProteinsTranscription Factorsbase excision repairCUX1OGG1radioresistance

Identifiers

PMID28147323
PMCPMC5386666
OpenAlexW2581339147

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.